Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoInk Appoints Russel A. Bantham to Its Board of Directors

Abstract:
NanoInk, Inc., an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries, announced today the appointment of Russel A. Bantham to its Board of Directors.

NanoInk Appoints Russel A. Bantham to Its Board of Directors

SKOKIE, IL | Posted on April 28th, 2008

„We‚re thrilled to have Russel Bantham join our esteemed Board of Directors,‰ said Jim Hussey, CEO, NanoInk. „With over 35 years of experience and leadership in the health care and pharmaceutical industries, Russel will be a valuable asset to our board.‰

Mr. Bantham worked at the Pharmaceutical Research and Manufacturers of America (PhRMA) from 1995 to 2005. As its executive vice president and COO, he was responsible for operations and had a staff of 160 with an annual budget in excess of $200 million. Before becoming COO at PhRMA, Mr. Bantham was senior vice president, general counsel and secretary where he was responsible for legal affairs and general management of PhRMA including strategy; science and regulatory affairs; and federal, state and international legislation and regulation.

Prior to PhRMA, Mr. Bantham spent 25 years at Bristol-Myers Squibb in a variety of positions, most recently as vice president and associate general counsel.

"Having spent the majority of my career in the health care and pharmaceutical industries, I understand the unique challenges NanoInk faces in bringing its brand protection solutions to the marketplace," said Bantham. "I look forward to advising the management team in its efforts to fuel the company‚s growth."

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPNÒ, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nano 'sandwich' offers unique properties: Rice University researchers simulate two-dimensional hybrids for optoelectronics February 27th, 2017

Dream Chip Technologies Presents First 22nm FD-SOI Silicon of New Automotive Driver Assistance SoC: Advanced driver assistance system (ADAS) computer vision SoC developed for European THINGS2DO project with working first silicon fabricated on GLOBALFOUNDRIES’ 22nm FD-SOI Platfor February 27th, 2017

Sandia use confined nanoparticles to improve hydrogen storage materials performance: Big changes from a small package for hydrogen storage February 25th, 2017

New nano approach could cut dose of leading HIV treatment in half February 24th, 2017

Law enforcement/Anti-Counterfeiting/Security/Loss prevention

NUS engineers develop low-cost, flexible terahertz radiation source for fast, non-invasive screening: Novel invention presents promising applications in spectroscopy, safety surveillance, cancer diagnosis, imaging and communication February 1st, 2017

Strength of hair inspires new materials for body armor January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Manchester scientists tie the tightest knot ever achieved January 13th, 2017

Announcements

Nano 'sandwich' offers unique properties: Rice University researchers simulate two-dimensional hybrids for optoelectronics February 27th, 2017

Dream Chip Technologies Presents First 22nm FD-SOI Silicon of New Automotive Driver Assistance SoC: Advanced driver assistance system (ADAS) computer vision SoC developed for European THINGS2DO project with working first silicon fabricated on GLOBALFOUNDRIES’ 22nm FD-SOI Platfor February 27th, 2017

Sandia use confined nanoparticles to improve hydrogen storage materials performance: Big changes from a small package for hydrogen storage February 25th, 2017

New nano approach could cut dose of leading HIV treatment in half February 24th, 2017

Patents/IP/Tech Transfer/Licensing

Keystone Nano Announces The US FDA Has Awarded Orphan Drug Designation For Ceramides For The Treatment Of Liver Cancer November 8th, 2016

Leti to Tackle Tomorrow's Research Strategies with Stanford University’s SystemX Alliance: French R&D Center Is the First Research Institute to Join the Collaboration and Provides Bridges Between Academia and Industry, Leveraging Alliance’s Potential October 4th, 2016

Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016

NIST Patents Single-Photon Detector for Potential Encryption and Sensing Apps September 16th, 2016

Appointments/Promotions/New hires/Resignations/Deaths

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project